AMR Innovation Mission UK 2021
Antimicrobial Resistance (AMR) is a global societal problem that is recognised as needing a rapid global response. At the same time this offers huge business opportunities for those developing the solutions.
It is recognised that Research and Innovation is becoming more global and collaborative.
Boosting the entire value chain
The AMR Innovation Mission UK 2021 aims to add to the global curbing of AMR by boosting joint early & translational research, R&D, clinical development, validation, registration and commercialisation of vaccines, microbial diagnostics and antimicrobial products. It facilitates international dialogues for the UK business community to help them develop their technologies utilising the best science nationally and internationally.
A Virtual and a Physical Mission
A Virtual Mission will take place 10-12 May 2021, involving keynote speakers, update on funding initiatives and partnering events. This will be followed by a physical, face-to-face mission 11-15 October 2021.
The AMR Innovation Mission UK 2021 is an initiative of AMR Insights and is realised in collaboration with Innovate UK EDGE, Oxford Innovation, Enterprise Europe Network (EEN) and NIHR: